Medicine shortages in Tehran pharmacies
The pharmaceutical market in Iran, particularly in Tehran, is experiencing a severe crisis with the depletion of dozens of essential medications, including insulin. This shortage is due to a lack of locally produced raw materials and the high costs of imported alternatives. The crisis is linked to the economic sanctions imposed on the country, which have disrupted the import of raw materials and worsened the medicine shortage. As a result, patients have been forced to turn to the black market at elevated prices. The situation has worsened due to the suspension of preferential currency support for the pharmaceutical sector and the collapse of liquidity among manufacturing companies, with warnings about health consequences and an urgent need for measures to ensure broad access to medicines.
Notice: This Is an AI-Generated Summary
Comments (0)